Bright Minds Biosciences has a strong translational science foundation to support our drug development. We have a rich and growing library of proprietary compounds targeting the 5-HT_2C, 5-HT_2A/C and 5-HT_2A receptors. By using intelligent drug design and advanced molecular modeling, and scientifically rigorous evaluation in pre-clinical models of brain function at the network level, our team can select compounds with the best activity profile for advancing into clinical trials in patients. Our data driven decision process allows us to de-risk our compounds to maximize the chance of success in clinical trials.